Pneumococcal vaccine shows high efficacy rate

11/16/2012 | PhysiciansBriefing.com

A pediatric study of the pneumococcal vaccine PHiD-CV10 showed efficacy rates of 100% and 92% for the 3+1 and 2+1 vaccination schedules, respectively. "For the first time, effectiveness of a 2+1 schedule in infants was confirmed in a clinical trial," Finnish researchers reported in the journal The Lancet.

View Full Article in:

PhysiciansBriefing.com

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr Statistician I (US/TB/00/0028/SL)
Abbott
Santa Clara, CA
Food & Drug Associate
Confidential
Washington, D.C., DC
Senior Manager, Gaps in Care
UAW Retiree Medical Benefits Trust
Detroit, MI
Compliance Director
Abbott Laboratories
Santa Clara, CA
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA